You are here

Vaccinations

COVID overview: The Year in Review

This year's headlines on COVID-19 featured new research on COVID-related mortality, post-acute sequelae of infection, vaccine safety, and potential therapeutics.

COVID Deaths Are Down, but...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Research into why protective antibodies fade after COVID-19 vaccines --NIH

  • Researchers found that current COVID-19 vaccines fail to generate mature and durable antibody-producing cells in the bone marrow.
  • The findings could help explain why protection tends to decline over time.
  • Better understanding of long-term immune responses could lead to improved vaccines that provide enduring protection.
  • ...
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Distrust among various groups hindered COVID vaccination efforts --Brithis study

'Perfect storm' of distrust deepened inequalities during COVID-19 pandemic

...

Research led by University of Manchester academics, examined the attitudes of people from minoritized ethnic groups, and those with long-term physical and mental health conditions toward the COVID-19 vaccination program.

Researchers found that a "perfect storm" of marginalization and experience of structural inequalities led to distrust of the COVID-19 vaccination drive—and that marginalized communities felt "left behind" by policy and decision-makers prior to and during the .

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. CDC recommends expanding pneumococcal vaccines to adults aged 50-64

U.S. CDC recommends expanding pneumococcal vaccines to adults aged 50-64

Oct 24 (Reuters) - The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease.
The agency's earlier recommendation for vaccination was for adults 65 years or older and children younger than 5, as well as for children and adults with certain conditions.
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Vaccinations
howdy folks
Page loaded in 0.751 seconds.